The platform will undergo maintenance on Sep 14 at about 7:45 AM EST and will be unavailable for approximately 2 hours.
2019
DOI: 10.1016/j.jtemb.2019.01.017
|View full text |Cite
|
Sign up to set email alerts
|

Organoselenotriazoles attenuate oxidative damage induced by mitochondrial dysfunction in mev-1 Caenorhabditis elegans mutants

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
8
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 15 publications
(13 citation statements)
references
References 50 publications
1
8
0
Order By: Relevance
“…SODs perform their bio-protective role by converting superoxide into molecular oxygen and hydrogen peroxide by cyclic redox reactions containing a metal (Mn, Zn, Cu or Fe) at the active site, and for this reason it is considered a molecular drug target (Azadmanesh & Borgstahl 2018, Bonetta 2017. The expression of these enzymes can be modulated by xenobiotics, and our group has been focused on investigating the molecular targets of molecules named organochalcogens (Wollenhaupt et al 2014, Avila et al 2012, Salgueiro et al 2017, Soares et al 2019.…”
Section: Introductionmentioning
confidence: 99%
“…SODs perform their bio-protective role by converting superoxide into molecular oxygen and hydrogen peroxide by cyclic redox reactions containing a metal (Mn, Zn, Cu or Fe) at the active site, and for this reason it is considered a molecular drug target (Azadmanesh & Borgstahl 2018, Bonetta 2017. The expression of these enzymes can be modulated by xenobiotics, and our group has been focused on investigating the molecular targets of molecules named organochalcogens (Wollenhaupt et al 2014, Avila et al 2012, Salgueiro et al 2017, Soares et al 2019.…”
Section: Introductionmentioning
confidence: 99%
“…An in vivo study was conducted on a Caenorhabditis elegans worm model. Compared to the RSH "isoforms," the present molecules have great reducing potential [33]. found to be selective towards HDAC6.…”
Section: Selenium In Therapeutics Medicinal Chemistry and Skeleton Coresmentioning
confidence: 95%
“…An in vivo study was conducted on a Caenorhabditis elegans worm model. Compared to the RSH "isoforms," the present molecules have great reducing potential [33]. In relationship to H2S signaling, persulfides and selenosulfides and the R-SeSH motif containing compounds were importantly produced, studied and discussed by Kang et al The article by Soares et al is based on a series of organoselenotriazole compounds and the notion of mitochondrial dysfunction; the selenium-containing enzymes have selenium in the form of R-SeH groups (Figure 9).…”
Section: Selenium In Therapeutics Medicinal Chemistry and Skeleton Coresmentioning
confidence: 99%
See 1 more Smart Citation
“…focused on developing prospective drug candidates [11][12][13][14][15][16][17][18][19][20] ; however, the most famous selenium drug candidate so far is ebselen, which contains Se-N bonds. It is a multifunctional compound that catalyzes several essential reactions (e.g., reduces reactive oxygen species (ROS) in a manner similar to glutathione peroxidase (GPx), and highly efficiently oxidizes reduced thioredoxin and catalyzes hydrogen peroxide reduction by thioredoxin reductase (TrxR), which acts as a dehydroascorbic acid (DHA) reductase mimetic) for the protection of cellular components from oxidative and free radical damage 21 .…”
mentioning
confidence: 99%